News & Trends - Biotechnology

AusBiotech champions Australia’s momentum in the global life sciences race

AusBiotech has wrapped up a week packed with bilateral and multilateral engagements at the BIO International Convention 2025 in Boston. […]

News & Trends - Biotechnology

Local biotech earns green light to manufacture next-gen cell therapies

A Melbourne-based biotech company has secured a stem cell manufacturing licence from the Therapeutic Goods Administration (TGA), a move that […]

News & Trends - Biotechnology

NRF backs local ophthalmic biotech

A Melbourne-based biotechnology company has landed a game-changing investment to push forward its novel glaucoma implant to address the long-standing […]

News & Trends - Biotechnology

Purpose, policy and the future of clinical trials: Noxopharm CEO on what’s next for Australian biotech

As the world marks Clinical Trials Day (20 May), Dr Gisela Mautner, CEO of ASX-listed biotech Noxopharm, brings a bold […]

News & Trends - Biotechnology

World-first trial 3D prints skin directly onto wounds using robotic technology

In a world-first clinical trial, a robot developed by an Australian biotech company is being used to 3D print human […]

News & Trends - Biotechnology

Immunotherapy combo doubles survival in hard-to-treat head and neck cancer, challenging standard of care

An ASX-listed biotech has released new survival data demonstrating the potential of its novel immunotherapy combination in first-line recurrent or […]

News & Trends - Biotechnology

Government backs industry and research partners in regenerative therapy manufacturing

Australia’s push to lead in regenerative therapy manufacturing has taken a major leap forward with the federal government announcing $65 […]

News & Trends - Biotechnology

Local biotech kicks off phase 3 trial for lung cancer combination therapy

ASX-listed biotech company Immutep has reached a major milestone, announcing that the first patient has been successfully dosed in its […]

News & Trends - Biotechnology

Aussie biotech announces R&D partnership for first in-human trial in lupus

ASX listed biotech company Noxopharm has engaged a highly-regarded Australian phase 1 unit to deliver the upcoming HERACLES clinical trial. […]

News & Trends - Biotechnology

AusBiotech and Medicines Australia IWD luncheon: A collective voice for bold action on gender equity

AusBiotech and Medicines Australia are joining forces to host the highly anticipated annual Women in Life Sciences luncheon, set to […]